ATE123878T1 - Methode und vorrichtung für heterogene chemilumineszenz-untersuchungen. - Google Patents

Methode und vorrichtung für heterogene chemilumineszenz-untersuchungen.

Info

Publication number
ATE123878T1
ATE123878T1 AT90116380T AT90116380T ATE123878T1 AT E123878 T1 ATE123878 T1 AT E123878T1 AT 90116380 T AT90116380 T AT 90116380T AT 90116380 T AT90116380 T AT 90116380T AT E123878 T1 ATE123878 T1 AT E123878T1
Authority
AT
Austria
Prior art keywords
chemiluminescent reaction
porous element
solid
investigations
reaction complex
Prior art date
Application number
AT90116380T
Other languages
English (en)
Inventor
Omar S Khalil
Thomas F Zurek
Kevin R Genger
Curtis J Pepe
Yi-Her Jou
Stephen M Cotter
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE123878T1 publication Critical patent/ATE123878T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J37/00Discharge tubes with provision for introducing objects or material to be exposed to the discharge, e.g. for the purpose of examination or processing thereof
    • H01J37/32Gas-filled discharge tubes
    • H01J37/32431Constructional details of the reactor
    • H01J37/32623Mechanical discharge control means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • G01N33/5764Hepatitis B surface antigen
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J37/00Discharge tubes with provision for introducing objects or material to be exposed to the discharge, e.g. for the purpose of examination or processing thereof
    • H01J37/32Gas-filled discharge tubes
    • H01J37/32431Constructional details of the reactor
    • H01J37/32697Electrostatic control
    • H01J37/32706Polarising the substrate
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10PGENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P50/00Etching of wafers, substrates or parts of devices
    • H10P50/20Dry etching; Plasma etching; Reactive-ion etching
    • H10P50/24Dry etching; Plasma etching; Reactive-ion etching of semiconductor materials
    • H10P50/242Dry etching; Plasma etching; Reactive-ion etching of semiconductor materials of Group IV materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10PGENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P50/00Etching of wafers, substrates or parts of devices
    • H10P50/20Dry etching; Plasma etching; Reactive-ion etching
    • H10P50/24Dry etching; Plasma etching; Reactive-ion etching of semiconductor materials
    • H10P50/242Dry etching; Plasma etching; Reactive-ion etching of semiconductor materials of Group IV materials
    • H10P50/244Dry etching; Plasma etching; Reactive-ion etching of semiconductor materials of Group IV materials comprising alternated and repeated etching and passivation steps
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10PGENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P50/00Etching of wafers, substrates or parts of devices
    • H10P50/20Dry etching; Plasma etching; Reactive-ion etching
    • H10P50/26Dry etching; Plasma etching; Reactive-ion etching of conductive or resistive materials
    • H10P50/264Dry etching; Plasma etching; Reactive-ion etching of conductive or resistive materials by chemical means
    • H10P50/266Dry etching; Plasma etching; Reactive-ion etching of conductive or resistive materials by chemical means by vapour etching only
    • H10P50/267Dry etching; Plasma etching; Reactive-ion etching of conductive or resistive materials by chemical means by vapour etching only using plasmas
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76Chemiluminescence; Bioluminescence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Nanotechnology (AREA)
  • Plasma & Fusion (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT90116380T 1989-10-23 1990-08-27 Methode und vorrichtung für heterogene chemilumineszenz-untersuchungen. ATE123878T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/425,643 US5089424A (en) 1988-06-14 1989-10-23 Method and apparatus for heterogeneous chemiluminescence assay

Publications (1)

Publication Number Publication Date
ATE123878T1 true ATE123878T1 (de) 1995-06-15

Family

ID=23687434

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90116380T ATE123878T1 (de) 1989-10-23 1990-08-27 Methode und vorrichtung für heterogene chemilumineszenz-untersuchungen.

Country Status (9)

Country Link
US (1) US5089424A (de)
EP (1) EP0424634B1 (de)
JP (1) JP2664279B2 (de)
KR (1) KR910008409A (de)
AT (1) ATE123878T1 (de)
AU (1) AU635549B2 (de)
CA (1) CA2021586C (de)
DE (1) DE69020094T2 (de)
ES (1) ES2075861T3 (de)

Families Citing this family (209)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436349B1 (en) 1991-03-04 2002-08-20 Bayer Corporation Fluid handling apparatus for an automated analyzer
US20060013729A1 (en) * 1991-02-14 2006-01-19 Glen Carey Fluid handling apparatus for an automated analyzer
US6498037B1 (en) * 1991-03-04 2002-12-24 Bayer Corporation Method of handling reagents in a random access protocol
CA2384519C (en) * 1991-03-04 2006-08-15 Bayer Corporation Automated analyzer
DE4123818C2 (de) * 1991-07-18 1994-05-19 Berthold Lab Prof Dr Vorrichtung zur Messung der Chemilumineszenz einer in einem Probengefäß befindlichen Probe
EP0584343B1 (de) * 1992-03-10 1999-01-20 La Jolla Cancer Research Foundation Rekombinierte alkalische phosphatase aus kälberdarm
EP1380843A3 (de) 1992-03-27 2010-01-13 Abbott Laboratories Automatische Flüssigkeitspegelsensorvorrichtung
US6399397B1 (en) * 1992-09-14 2002-06-04 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
WO1994012885A1 (fr) * 1992-11-20 1994-06-09 Dainabot Co., Ltd. Systeme d'immunodosage automatique a canaux multiples
US5441894A (en) * 1993-04-30 1995-08-15 Abbott Laboratories Device containing a light absorbing element for automated chemiluminescent immunoassays
EP0651253A1 (de) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay zum Nachweis menschlicher Autoantikörper
US5468649A (en) * 1994-02-15 1995-11-21 Abbott Laboratories Process for labeling acridinium to microparticles and application in an instrument
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US5599501A (en) * 1994-11-10 1997-02-04 Ciba Corning Diagnostics Corp. Incubation chamber
JPH08136546A (ja) * 1994-11-15 1996-05-31 Bio Sensor Kenkyusho:Kk 物質分析法
WO1996040763A2 (en) * 1995-06-07 1996-12-19 Abbott Laboratories Peptides for hiv-1 detection
US5686046A (en) * 1995-07-13 1997-11-11 Chiron Diagnostics Corporation Luminometer
US5735387A (en) * 1995-07-14 1998-04-07 Chiron Diagnostics Corporation Specimen rack handling system
US5720377A (en) * 1995-07-14 1998-02-24 Chiron Diagnostics Corporation Magnetic conveyor system
US6501549B1 (en) 1995-12-05 2002-12-31 University Of Utah Research Foundation Method of measuring chemical concentration based on spatial separation and resolution of luminescence
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US6056923A (en) * 1997-06-25 2000-05-02 Clmp, Inc. Dual injector for chemiluminescence immunoanalyzing system
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6203974B1 (en) 1998-09-03 2001-03-20 Abbott Laboratories Chemiluminescent immunoassay for detection of antibodies to various viruses
US6794156B2 (en) * 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
US6686171B2 (en) * 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
ES2165320B1 (es) * 2000-05-03 2003-06-16 Dentaid S L Dispositivo optico para la cuantificacion de compuestos volatiles de azufre (cvs) a traves de medidas de absorcion/reflectancia.
EP1355666B1 (de) 2000-12-22 2012-06-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von "repulsive guidance molecule" (rgm) und von dessen modulatoren
DE10136865B4 (de) * 2001-07-28 2007-11-15 Berthold Technologies Gmbh & Co. Kg Vorrichtung zur Messung der Chemilumineszenz
ATE454470T1 (de) 2002-07-26 2010-01-15 Abbott Lab Verfahren zum nachweis und zur quantifizierung von hepatitis-c-virus
US20040024193A1 (en) 2002-07-26 2004-02-05 Williams Gregg T. Method of detecting and quantifying hepatitis C virus
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
CA2554755A1 (en) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US20070037232A1 (en) 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US8624027B2 (en) 2005-05-12 2014-01-07 Abbvie Inc. Combination therapy for treating cancer and diagnostic assays for use therein
US8906864B2 (en) * 2005-09-30 2014-12-09 AbbVie Deutschland GmbH & Co. KG Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
US20080220448A1 (en) * 2006-09-01 2008-09-11 Blincko Stuart J Antigenic protein conjugates and process for preparing same
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
EP2097750A2 (de) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay aus analyten in proben mit endogenen antikörpern gegen analyte
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
KR100824388B1 (ko) * 2006-12-06 2008-04-22 한국타이어 주식회사 화학발광을 이용한 타이어 부위 별 노화측정방법
US7858924B2 (en) 2006-12-12 2010-12-28 Abbott Laboratories, Inc. Device for use in normalizing readings on a testing machine
US7914999B2 (en) 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
JP5026849B2 (ja) * 2007-04-20 2012-09-19 株式会社日立製作所 化学発光計測装置
US20080280377A1 (en) 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
US8288111B2 (en) * 2007-05-24 2012-10-16 Abbott Laboratories Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites
US20090053736A1 (en) * 2007-08-21 2009-02-26 Mattingly Phillip G Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins
US7608361B2 (en) * 2007-08-22 2009-10-27 Stauffer John E Alkali metal battery
EP2033971A1 (de) * 2007-09-06 2009-03-11 Abbott GmbH & Co. KG Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
US20090068635A1 (en) * 2007-09-06 2009-03-12 Muerhoff Anthony S Indirectly labelled assay conjugates and methods of preparing and using same
US20100136520A1 (en) * 2007-09-13 2010-06-03 Abbott Laboratories Detecting hepatitis b virus
US8138318B2 (en) 2007-09-13 2012-03-20 Abbott Laboratories Hepatitis B pre-S2 nucleic acid
US20090098531A1 (en) * 2007-09-13 2009-04-16 Abbott Laboratories Detecting hepatitis b virus
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
CA2700378A1 (en) * 2007-09-21 2009-03-29 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
JP5848006B2 (ja) 2007-10-19 2016-01-27 アボット・ラボラトリーズAbbott Laboratories Ngalの検出用イムノアッセイ及びキット
US20100267055A1 (en) * 2007-10-21 2010-10-21 Abbott Laboratories One-step immunoassays exhibiting increased sensitivity and specificity
US8283124B2 (en) * 2007-10-25 2012-10-09 Abbott Laboratories Compositions for detecting antibodies to Babesia microti and methods of uses thereof
ES2559311T3 (es) 2007-12-19 2016-02-11 Abbott Laboratories Reactivo de extracción de fármacos inmunosupresores para inmunoanálisis
CN101387650B (zh) * 2007-12-20 2012-06-27 北京科美生物技术有限公司 全自动板式发光仪及其发光检测方法
DE202008009859U1 (de) * 2007-12-21 2009-03-05 Berthold Technologies Gmbh & Co. Kg Vorrichtung zur wahlweisen Messung von insbesondere Lumineszenz- und/oder Fluoreszenzstrahlung
ES2539026T3 (es) 2007-12-27 2015-06-25 Abbott Laboratories Anticuerpos anti-T. cruzi y métodos de uso
US20090203038A1 (en) * 2007-12-27 2009-08-13 Abbott Laboratories Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
US8268981B2 (en) 2008-03-06 2012-09-18 Abbott Laboratories Plasmodium malariae and plasmodium ovale genes and uses thereof
US8030471B2 (en) * 2008-03-06 2011-10-04 Abbott Laboratories Plasmodium malariae and Plasmodium ovale genes and uses thereof
JP5646457B2 (ja) 2008-04-29 2014-12-24 アッヴィ・インコーポレイテッド 二重可変ドメイン免疫グロブリン及びその使用
US20090286329A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratoires Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
JP2011523853A (ja) 2008-06-03 2011-08-25 アボット・ラボラトリーズ 二重可変ドメイン免疫グロブリン及びその使用
US20100015655A1 (en) * 2008-07-17 2010-01-21 Abbott Laboratories Methods and Kits for Detecting and Quantifying Damage Caused by a Parasite
US20100240024A1 (en) * 2008-09-03 2010-09-23 Abbott Laboratories Assays And Kits For Determining HIV-1 Tropism
US20100105150A1 (en) * 2008-10-24 2010-04-29 Abbott Laboratories Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal
US8349325B2 (en) 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
US8168165B2 (en) 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
US8241915B2 (en) * 2009-01-14 2012-08-14 Abbott Laboratories Methods and kits for detecting hemoglobin in test samples
EP2479288A1 (de) 2009-01-31 2012-07-25 Abbott Laboratories Marker zur Vorhersage und Überwachung der Reaktion auf eine Therapie mit einem Aurorakinase-B-Inhibitor
JP2012517241A (ja) 2009-02-11 2012-08-02 アボット・ラボラトリーズ Bcl−2ファミリー阻害剤耐性腫瘍及び癌を有する被験者を同定、分類及びモニターするための方法及び組成物
US8030026B2 (en) * 2009-02-24 2011-10-04 Abbott Laboratories Antibodies to troponin I and methods of use thereof
SG173705A1 (en) 2009-03-05 2011-09-29 Abbott Lab Il-17 binding proteins
US8283162B2 (en) * 2009-03-10 2012-10-09 Abbott Laboratories Antibodies relating to PIVKAII and uses thereof
US8063193B2 (en) 2009-03-27 2011-11-22 Abbott Laboratories Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
CN201404734Y (zh) * 2009-04-28 2010-02-17 厦门市毕恩生物技术有限公司 底部控制式标本过滤容器
US20100291709A1 (en) * 2009-05-13 2010-11-18 Abbott Laboratories Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
US8183349B2 (en) 2009-06-30 2012-05-22 Abbott Laboratories Markers of XMRV infection and uses thereof
MX336152B (es) 2009-08-29 2016-01-08 Abbvie Inc Proteinas terapeutico de union a dll4.
JP5715137B2 (ja) * 2009-08-31 2015-05-07 アボット・ラボラトリーズAbbott Laboratories 主要有害心イベントの予測のためのバイオマーカーおよびその使用
JP5205354B2 (ja) * 2009-09-30 2013-06-05 富士フイルム株式会社 クロマトグラフ測定装置
US8455212B2 (en) 2009-11-21 2013-06-04 Abbott Laboratories Assays for human NT-pro B-type natriuretic peptide, human pro B-type natriuretic peptide and human B-type natriuretic peptide
US8835120B2 (en) 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US8652788B2 (en) 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
US8183002B2 (en) 2009-12-03 2012-05-22 Abbott Laboratories Autoantibody enhanced immunoassays and kits
US20110136141A1 (en) 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
MX2012006560A (es) * 2009-12-08 2012-10-05 Abbott Gmbh & Co Kg Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
EP3072904A1 (de) 2010-03-02 2016-09-28 Abbvie Inc. Therapeutische dll4-bindende proteine
US20110229921A1 (en) * 2010-03-18 2011-09-22 Abbott Laboratories METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
JP5786020B2 (ja) 2010-04-16 2015-09-30 アボットジャパン株式会社 関節リウマチを診断する方法および試薬
JP5524698B2 (ja) * 2010-04-27 2014-06-18 株式会社日立ハイテクノロジーズ 自動分析装置
CN102236013A (zh) * 2010-04-28 2011-11-09 上海捷瑞医用试剂有限公司 化学发光免疫分析仪用浓缩缓冲液及其制备方法
US20120190563A1 (en) 2010-05-07 2012-07-26 Abbott Laboratories Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
JP2013525814A (ja) 2010-05-07 2013-06-20 アッヴィ・インコーポレイテッド 標的化チロシンキナーゼインヒビターでの治療に対する感受性の予測方法
MY161302A (en) 2010-05-14 2017-04-14 Abbvie Inc IL-1 binding proteins
US9551714B2 (en) 2010-06-25 2017-01-24 Abbott Laboratories Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
US20120009196A1 (en) 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
UY33492A (es) 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
US9120862B2 (en) 2010-07-26 2015-09-01 Abbott Laboratories Antibodies relating to PIVKA-II and uses thereof
EP3252072A3 (de) 2010-08-03 2018-03-14 AbbVie Inc. Immunglobuline mit zweifacher variabler domäne und verwendungen davon
US20120058461A1 (en) 2010-08-18 2012-03-08 Abbott Laboratories Molecular detection of xmrv infection
US20120058462A1 (en) 2010-08-18 2012-03-08 Abbott Laboratories Molecular detection of xmrv infection
SG187938A1 (en) 2010-08-26 2013-04-30 Abbvie Inc Dual variable domain immunoglobulins and uses thereof
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
AU2011361720B2 (en) 2010-12-21 2017-04-27 Abbvie Inc. IL-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use
SG10201600531TA (en) 2011-01-24 2016-02-26 Univ Singapore Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
CN105388287A (zh) 2011-03-11 2016-03-09 内布拉斯加大学董事委员会 冠状动脉疾病的生物标志物
JP2014515476A (ja) 2011-05-20 2014-06-30 アボットジャパン株式会社 非特異的結合を減少させるためのイムノアッセイ方法及び試薬
US10641768B2 (en) 2011-07-08 2020-05-05 Abbott Japan Co. Ltd. Methods and kits for decreasing interferences from leukocytes in specific binding assays
WO2013009705A2 (en) 2011-07-09 2013-01-17 The Trustees Of Columbia University In The City Of New York Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism
MX2014004980A (es) 2011-10-24 2014-09-11 Abbvie Inc Inmunoaglutinantes biespecificos dirigidos contra tnf e il-17.
UY34411A (es) 2011-10-24 2013-05-31 Abbvie Inc Inmunoenlazantes dirigidos contra esclerostina
CA2855570A1 (en) 2011-12-14 2013-06-20 AbbVie Deutschland GmbH & Co. KG Composition and method for the diagnosis and treatment of iron-related disorders
JP6342812B2 (ja) 2011-12-14 2018-06-13 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー 鉄関連障害を診断および治療するための組成物および方法
CN104159920A (zh) 2011-12-30 2014-11-19 艾伯维公司 针对il-13和/或il-17的双重可变结构域免疫球蛋白
AR090047A1 (es) 2011-12-30 2014-10-15 Abbvie Inc Dominio variable dual de inmunoglobulinas y sus usos
US8993248B2 (en) 2011-12-31 2015-03-31 Abbott Laboratories Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
PE20190907A1 (es) 2012-01-27 2019-06-26 AbbVie Deutschland GmbH and Co KG Composicion y metodo para el diagnostico y el tratamiento de las enfermedades asociadas a la degeneracion de las neuritas
WO2014011955A2 (en) 2012-07-12 2014-01-16 Abbvie, Inc. Il-1 binding proteins
EP2893320B1 (de) * 2012-08-20 2020-12-23 Siemens Healthcare Diagnostics Inc. Zweischaliges luminometer
CN102798718A (zh) * 2012-08-31 2012-11-28 福建省洪诚生物药业有限公司 乙肝病毒前s1抗原检测试剂盒及其制备方法
MY171664A (en) 2012-11-01 2019-10-22 Abbvie Inc Anti-dll4/vegf dual variable domain immunoglobulins and uses thereof
CA2890455A1 (en) 2012-12-04 2014-06-12 Abbvie, Inc. Blood-brain barrier (bbb) penetrating dual specific binding proteins
EP2938634A2 (de) 2012-12-28 2015-11-04 AbbVie Inc. Spezifische doppeltbindende proteine mit einer rezeptorsequenz
US9856319B2 (en) 2012-12-28 2018-01-02 Abbvie Inc. Monovalent binding proteins
WO2014116846A2 (en) 2013-01-23 2014-07-31 Abbvie, Inc. Methods and compositions for modulating an immune response
US20140271453A1 (en) 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
MX2015012824A (es) 2013-03-14 2016-06-24 Abbott Lab Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
BR112015023239A8 (pt) 2013-03-14 2018-04-17 Abbott Lab ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
US9651547B2 (en) 2013-03-14 2017-05-16 Abbott Point Of Care Inc. Electrochemical methods and devices for amending urine samples for immunosensor detection
US9488663B2 (en) 2013-03-14 2016-11-08 Abbott Point Of Care Inc. Electrochemical methods and devices for amending urine samples for immunosensor detection
MX376492B (es) 2013-03-14 2025-03-07 Abbott Lab Anticuerpos monoclonares que se unen al dominio de unión a lípidos de la proteína de la cápside del virus de la hepatitis c (vhc)
WO2014144299A2 (en) 2013-03-15 2014-09-18 Abbvie Inc. DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST TNFα
US9157910B2 (en) 2013-03-15 2015-10-13 Abbott Laboratories Assay with increased dynamic range
US9005901B2 (en) 2013-03-15 2015-04-14 Abbott Laboratories Assay with internal calibration
JP2016522793A (ja) 2013-03-15 2016-08-04 アッヴィ・インコーポレイテッド IL−1βおよび/またはIL−17に対して指向された二重特異的結合タンパク質
US9469686B2 (en) 2013-03-15 2016-10-18 Abbott Laboratories Anti-GP73 monoclonal antibodies and methods of obtaining the same
WO2015031626A1 (en) 2013-08-28 2015-03-05 Abbvie Inc. Soluble cmet assay
JP2016535765A (ja) 2013-10-06 2016-11-17 アビー・インコーポレイテッドAbbVie Inc. 免疫細胞受容体及び自己抗原を対象とする二重特異性結合タンパク質
NZ720353A (en) 2013-12-30 2019-12-20 Epimab Biotherapeutics Inc Fabs-in-tandem immunoglobulin and uses thereof
US20160002343A1 (en) 2014-06-11 2016-01-07 Abbvie Inc. Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
EP3161490B1 (de) 2014-06-27 2019-10-02 Abbott Laboratories Zusammensetzungen und verfahren zur detektion des menschlichen pegivirus 2 (hpgv-2)
JP6821562B2 (ja) 2014-10-29 2021-01-27 アボット・ラボラトリーズAbbott Laboratories Ns3捕捉ペプチドを使用して対象の抗hcv抗体を検出するアッセイ
WO2016094881A2 (en) 2014-12-11 2016-06-16 Abbvie Inc. Lrp-8 binding proteins
WO2016160976A2 (en) 2015-03-30 2016-10-06 Abbvie Inc. Monovalent tnf binding proteins
TW201710286A (zh) 2015-06-15 2017-03-16 艾伯維有限公司 抗vegf、pdgf及/或其受體之結合蛋白
US20170089905A1 (en) 2015-09-28 2017-03-30 Abbott Japan Co., Ltd. Methods of diagnosing hepatocellular carcinoma and pancreatic cancer
IL260937B2 (en) 2016-02-06 2024-07-01 Epimab Biotherapeutics Inc Fabs-in-tandem immunoglobulin and uses thereof
US20170363620A1 (en) 2016-06-17 2017-12-21 Abbott Laboratories BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
MX2019001134A (es) 2016-07-29 2019-04-11 Inst Tecnologico Estudios Superiores Monterrey Sistemas y metodos para la deteccion de reacciones quimioluminiscentes.
EP3279667A1 (de) 2016-08-02 2018-02-07 Abbott Laboratories Herz-troponin i und copeptin als biomarker für kurzfristige sterblichkeit bei akuter exazerbation von chronisch obstruktiver lungenerkrankung (aecopd)
US10722882B2 (en) * 2016-08-03 2020-07-28 Pierce Biotechnology, Inc. Chemiluminescent and fluorescent substrate pads and uses thereof
WO2018067468A1 (en) 2016-10-03 2018-04-12 Abbott Laboratories Improved methods of assessing uch-l1 status in patient samples
CA3052513A1 (en) 2017-03-23 2018-09-27 Abbott Laboratories Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
CN106980024A (zh) * 2017-03-28 2017-07-25 杭州凯坤科技有限公司 一种全自动光激化学发光检测仪
ES3055047T3 (en) 2017-04-15 2026-02-09 Abbott Lab Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
CN110603449A (zh) 2017-04-28 2019-12-20 雅培实验室 用同一人受试者的至少两种样品的早期生物标记物帮助超急性诊断确定创伤性脑损伤的方法
WO2018218169A1 (en) 2017-05-25 2018-11-29 Abbott Laboratories Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
WO2018222783A1 (en) 2017-05-30 2018-12-06 Abbott Laboratories Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
EP3649474A1 (de) 2017-07-03 2020-05-13 Abbott Laboratories Verbesserte verfahren zur messung von ubiquitin-carboxy-terminalen hydrolase-l1-konzentrationen in blut
US11016105B2 (en) 2017-12-09 2021-05-25 Abbott Laboratories Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
EP3721233A2 (de) 2017-12-09 2020-10-14 Abbott Laboratories Verfahren zur unterstützung bei der diagnose und bewertung eines patienten, der eine orthopädische verletzung erlitten hat und der eine verletzung des kopfes wie eine leichte traumatische hirnverletzung (tbi) hat oder möglicherweise erlitten hat, unter verwendung eines glialen fibrillären sauren proteins (gfap) und/oder einer ubiquitin-carboxy-terminalen hydrolase l1 (uch-l1)
AU2018395255B2 (en) 2017-12-29 2025-02-20 Abbott Laboratories Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
ES3035098T3 (en) * 2018-02-02 2025-08-28 Nippon Chemiphar Co Biochemical reaction substrate and analysis device
EP3787746A1 (de) 2018-04-30 2021-03-10 Takeda Pharmaceutical Company Limited Bindeproteine vom cannabinoid-rezeptor typ 1 (cb1) und verwendungen davon
MX2020011588A (es) 2018-05-03 2020-12-07 Shanghai Epimab Biotherapeutics Co Ltd Anticuerpos de alta afinidad a pd-1 y lag-3 y proteinas de union bispecificas preparadas a partir de las mismas.
EP3788377A1 (de) 2018-05-04 2021-03-10 Abbott Laboratories Hbv-diagnostische, prognostische und therapeutische verfahren und produkte
US11079395B2 (en) 2019-03-01 2021-08-03 Abbott Laboratories Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
WO2021026403A1 (en) 2019-08-07 2021-02-11 Abbott Laboratories Methods for detecting assay interferents and increasing dynamic range
EP4134678B1 (de) * 2020-04-08 2025-01-08 Hitachi High-Tech Corporation Automatische analysevorrichtung
CA3175523A1 (en) 2020-04-13 2021-10-21 Antti Virtanen Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
CN111693514B (zh) * 2020-05-07 2022-07-05 四川轻化工大学 一种利用在线式液气转换的在线检测装置及方法
CA3177830A1 (en) 2020-05-13 2021-11-18 Maria BECONI Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
CA3188349A1 (en) 2020-08-04 2022-02-10 A. Scott Muerhoff Improved methods and kits for detecting sars-cov-2 protein in a sample
CA3198161A1 (en) 2020-12-01 2022-06-09 Beth MCQUISTON Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
WO2023102384A1 (en) 2021-11-30 2023-06-08 Abbott Laboratories Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
EP4271998A1 (de) 2020-12-30 2023-11-08 Abbott Laboratories Verfahren zur bestimmung des sars-cov-2-antigens und anti-sars-cov-2-antikörpers in einer probe
WO2022147178A1 (en) 2020-12-30 2022-07-07 Abbott Laboratories Improved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
AU2022279156A1 (en) 2021-05-18 2023-11-02 Abbott Laboratories Methods of evaluating brain injury in a pediatric subject
EP4356129A1 (de) 2021-06-14 2024-04-24 Abbott Laboratories Verfahren zur diagnose oder unterstützung der diagnose von hirnverletzungen durch akustische energie, elektromagnetische energie, überdruckwelle und/oder explosionswind
WO2023028186A1 (en) 2021-08-27 2023-03-02 Abbott Laboratories Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
CN118715440A (zh) 2021-08-31 2024-09-27 雅培实验室 诊断脑损伤的方法和系统
JP2024534849A (ja) 2021-08-31 2024-09-26 アボット・ラボラトリーズ 脳の損傷を診断する方法及びシステム
JP2024538608A (ja) 2021-09-30 2024-10-23 アボット・ラボラトリーズ 脳の損傷を診断する方法及びシステム
EP4578020A1 (de) 2022-08-26 2025-07-02 Abbott Laboratories Verwendung von herztroponin und galectin-3 zur differenzierung von myokardinfarkt typ i und typ ii
WO2024059692A1 (en) 2022-09-15 2024-03-21 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
KR20250068723A (ko) 2022-09-15 2025-05-16 아보트 러보러터리즈 경증 및 초경증 외상성 뇌 손상을 구분하기 위한 바이오마커 및 방법
AU2023376925A1 (en) 2022-11-10 2025-06-05 Abbott Laboratories Methods of identifying macrotroponin in biological samples
WO2024211475A1 (en) 2023-04-04 2024-10-10 Abbott Laboratories Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
EP4713686A1 (de) 2023-04-28 2026-03-25 Abbott Laboratories Diagnose von hepatozellulärem karzinom im spätstadium
WO2024226969A1 (en) 2023-04-28 2024-10-31 Abbott Point Of Care Inc. Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
WO2025085348A1 (en) 2023-10-16 2025-04-24 Abbott Laboratories Methods and systems for diagnosing orthopoxvirus infection
WO2025096899A1 (en) 2023-11-02 2025-05-08 Abbott Laboratories Immunoassays and methods for diagnosing hepatitis d virus (hdv) infection
WO2025145020A2 (en) 2023-12-28 2025-07-03 Abbott Laboratories Methods, systems, compounds, and kits for determining an analyte of interest in a test sample
WO2025193825A1 (en) 2024-03-13 2025-09-18 Abbott Laboratories Diagnosis and monitoring of liver disease
WO2025198859A1 (en) 2024-03-21 2025-09-25 Abbott Laboratories Synthesis of thyroid hormone derivatives and their role as calibrators for thyroid hormone immunoassays
WO2025230857A1 (en) 2024-05-01 2025-11-06 Abbott Laboratories Improved methods for determining cardiac myosin binding protein c in biological samples

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112927A (de) * 1971-09-21 1973-03-23
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
US4104026A (en) * 1976-03-12 1978-08-01 University Of Virginia Immunoassay separation technique
EP0025350A3 (de) * 1979-09-05 1981-06-10 Dynatech Ag Apparat zum Feststellen von Lumineszenz-Reaktionen
US4363874A (en) * 1981-08-07 1982-12-14 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation nondiffusing reflecting layer
JPS5832166A (ja) * 1981-08-21 1983-02-25 Hitachi Ltd 免疫定量用分析要素
JPS5929751U (ja) * 1982-08-19 1984-02-24 コニカ株式会社 血液の簡易型分析装置
JPS59170768A (ja) * 1983-03-17 1984-09-27 Fuji Photo Film Co Ltd 非アイソト−プアツセイ用多層分析要素およびそれを用いるアツセイ方法
US4652533A (en) * 1983-04-28 1987-03-24 Pandex Laboratories, Inc. Method of solid phase immunoassay incorporating a luminescent label
US4704255A (en) * 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US4552839A (en) * 1983-08-01 1985-11-12 Syntex (U.S.A.) Inc. Determination of analytes in particle-containing medium
JPS60149950A (ja) * 1984-01-17 1985-08-07 Hitachi Ltd ケミルミネツセントの検出法
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
CA1272127A (en) * 1985-04-04 1990-07-31 Hybritech Incorporated Solid phase system for use in ligand-receptor assays
JPS61275656A (ja) * 1985-05-31 1986-12-05 Hitachi Ltd リン光イムノアツセイ装置
US4623461A (en) * 1985-05-31 1986-11-18 Murex Corporation Transverse flow diagnostic device
JPS62103542A (ja) * 1985-07-22 1987-05-14 Fuji Photo Film Co Ltd 一体型多層分析要素
US4923680A (en) * 1987-09-18 1990-05-08 Eastman Kodak Company Test device containing an immunoassay filter with a flow-delaying polymer
AU609241B2 (en) * 1988-01-29 1991-04-26 Abbott Laboratories Ion-capture assays and devices

Also Published As

Publication number Publication date
KR910008409A (ko) 1991-05-31
JP2664279B2 (ja) 1997-10-15
EP0424634A3 (en) 1992-03-04
AU635549B2 (en) 1993-03-25
ES2075861T3 (es) 1995-10-16
JPH03154853A (ja) 1991-07-02
EP0424634B1 (de) 1995-06-14
EP0424634A2 (de) 1991-05-02
DE69020094D1 (de) 1995-07-20
CA2021586C (en) 2002-09-03
AU5984790A (en) 1991-04-26
CA2021586A1 (en) 1991-04-24
US5089424A (en) 1992-02-18
DE69020094T2 (de) 1996-03-07

Similar Documents

Publication Publication Date Title
ATE123878T1 (de) Methode und vorrichtung für heterogene chemilumineszenz-untersuchungen.
DE58908351D1 (de) Mit Reagenz ablösbar imprägnierte Trägermatrix.
DE60040794D1 (de) Verfahren zur Immobilisierung von Oligonukleotiden auf festem Trägermaterial
FI832633A7 (fi) Vermikuliitti immobilisoitujen biologisten materiaalien kantaja- alustana.
ATE185816T1 (de) In sol-gel immobilizierte lipase bearbeitet hydrophoben substanzen
DE3886412D1 (de) Verfahren zur immobilisierung von lipasen.
PT98564A (pt) Processo para a realizacao de processos catalizados por enzimas com cristais reticulados como forma de imobilizacao de enzimas e dispositivos que os contem
ATE10208T1 (de) Stabilisierte, waessrige loesung von co-enzymen zur verwendung in klinischen analysen; verfahren zur stabilisierung eines labilen co-enzyms in einer waessrigen loesung fuer die klinische analyse und regenzsatz fuer diese klinische analyse.
ATE129901T1 (de) Verfahren und verwendung für ortspezifische aktivierung von substanzen.
DE3863254D1 (de) Anlage zur aeroben biologischen reinigung von schadstoffhaltigem wasser.
DE68910899D1 (de) Verfahren zur katalytischen Abwasserbehandlung.
ATE75420T1 (de) Verfahren zur herstellung von ammoniak und zur hydrierung von olefinen.
ES2180543T3 (es) Seleccion basada en reacciones para la expresion de, y la concentracion de, restos cataliticos.
JPS5266682A (en) Immobilization of enzyme or microbial fungus
DE3683101D1 (de) Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen.
DE3761370D1 (de) Verfahren zur aktivierung von wasserstoffperoxid zur oxidationsbehandlung von schwer abbaubaren toxischen substanzen.
KR890701131A (ko) 면역근성 촉매의 제조
ES8206038A1 (es) Sistema fisico-bioquimico para la deteccion de sustancias deactividad antigenica.
FI872620A7 (fi) Menetelmä jätevesien biologiseksi puhdistamiseksi
BR7805506A (pt) Processo para purificacao de aguas de despejo,carregadas de substancias organicas,contendo calcio
ATE78598T1 (de) Immunassay unter benutzung der mikropartikelneutralisierung.
IT8722389A0 (it) Procedimento per la immobilizzazione chimica di sostanze biologicamente attive su silice.
DE3770329D1 (de) Wirbelbett zur durchfuehrung von gas-feststoffreaktionen.
FI830930A7 (fi) Menetelmä ja laitteet jätevesien biologiseksi puhdistamiseksi aktivoidun lietteen avulla.
DE3675905D1 (de) Verfahren zur biologischen denitrifizierung von wasser und vorrichtung zur durchfuehrung dieses verfahrens.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee